The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British ...

British equities closed higher on Wednesday, with healthcare and mining shares leading gains as global investors added risk ...

The purpose of the pharma package is to revise the current rules on medicines to make them more accessible to patients while keeping EU industry competitive.

The global single-cell analysis Market is expected to witness a growth rate of 14% in the next five years. Continuous ...

The Council has agreed its position on new rules that will make the EU’s pharmaceutical sector fairer and more competitive.

As global markets navigate the complexities of trade policies and inflationary pressures, Asian economies are experiencing varied impacts, with some regions showing resilience amid these uncertainties ...